CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.
October 21st 2024
Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.
Kathleen N. Moore Discusses New PARP Inhibitors for Ovarian Cancer
March 15th 2017Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.
Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer
March 13th 2017Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.
Elizabeth Swisher Discusses Rucaparib's Side Effects for Patients With Ovarian Cancer
March 13th 2017Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.